Results 31 to 40 of about 205 (161)

Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens

open access: yesBlood Advances, 2018
: T-cell responses to minor histocompatibility antigens (mHAs) mediate both antitumor immunity (graft-versus-leukemia [GVL]) and graft-versus-host disease (GVHD) in allogeneic stem cell transplant.
Jefferson L. Lansford   +12 more
doaj   +1 more source

Dual Lineages of Langerhans Cells Cooperate to Restore the Immune Barrier after Skin Injury

open access: yesAdvanced Science, EarlyView.
After skin injury, the epidermal immune barrier is rebuilt by two sources of Langerhans cells. Resident Langerhans cells first move into the wound during re‐epithelialization, guided by CXCR2 signaling. Later, recruited monocytes become long‐lived Langerhans cells.
Axel D. Schmitter‐Sánchez   +8 more
wiley   +1 more source

Minor Antigen Disparities Impede Induction of Long Lasting Chimerism and Tolerance through Bone Marrow Transplantation with Costimulation Blockade

open access: yesJournal of Immunology Research, 2016
Mixed chimerism and tolerance can be successfully induced in rodents through allogeneic bone marrow transplantation (BMT) with costimulation blockade (CB), but varying success rates have been reported with distinct models and protocols.
Sinda Bigenzahn   +8 more
doaj   +1 more source

Tolerogenic effect of noninherited maternal antigens in hematopoietic stem cell transplantation

open access: yesFrontiers in Immunology, 2012
Major histocompatibility complex antigens that provoke severe transplant reactions are referred to as the human leukocyte antigen (HLA) in human and as the H-2 in mice.
Masahiro eHirayama   +2 more
doaj   +1 more source

Evaluation of immunosuppression protocols for MHC-matched allogeneic iPS cell-based transplantation using a mouse skin transplantation model

open access: yesInflammation and Regeneration, 2022
Background Off-the-shelf major histocompatibility complex (MHC)-matched iPS cells (iPSC) can potentially initiate host immune responses because of the existence of numerous minor antigens.
Tomoki Kamatani   +8 more
doaj   +1 more source

In Search of Immunodominant Minor Histocompatibility Antigens [PDF]

open access: yesBiology of Blood and Marrow Transplantation, 2013
survival. Larger retrospective studies should parse out relapse risk in specific cytogenetic subgroups, to offer more guidance to the practicing clinician. Our hope is that this and other retrospective studies of MRD monitoring leads to an assessment of the prognostic impact of MRD in well-defined molecular and cytogenetic subsets of AML.
openaire   +2 more sources

Strategies for inducing diabetes in laboratory animals: Advances from chemical, surgical, immunologic, dietary, and genetic approaches

open access: yesAnimal Models and Experimental Medicine, EarlyView.
This review summarizes the principal experimental approaches used to induce diabetes in animal models. Strategies include chemical agents (streptozotocin, alloxan, dithizone, gold thioglucose), dietary interventions (high‐fat and high‐sugar diets), surgical methods (total or partial pancreatectomy), genetic models (db/db, ob/ob, Goto‐Kakizaki [GK ...
Milad Faraji   +2 more
wiley   +1 more source

Toward a network model of MHC class II-restricted antigen processing

open access: yesFrontiers in Immunology, 2013
The standard model of Major Histocompatibility Complex class II (MHCII)-restricted antigen processing depicts a straightforward, linear pathway: Internalized antigens are converted into peptides that load in a chaperone dependent manner onto nascent ...
Laurence C Eisenlohr   +2 more
doaj   +1 more source

TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility Antigens

open access: yesFrontiers in Immunology, 2020
Minor histocompatibility antigens (mHAgs) in allogeneic hematopoietic stem cell transplantation are highly immunogenic as they are foreign antigens and cause polymorphism between donors and recipients. Adoptive cell therapy with mHAg-specific T cells may
Yoshiki Akatsuka
doaj   +1 more source

A polymorphism in the splice donor site of ZNF419 results in the novel renal cell carcinoma-associated minor histocompatibility antigen ZAPHIR. [PDF]

open access: yesPLoS ONE, 2011
Nonmyeloablative allogeneic stem cell transplantation (SCT) can induce remission in patients with renal cell carcinoma (RCC), but this graft-versus-tumor (GVT) effect is often accompanied by graft-versus-host disease (GVHD).
Kelly Broen   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy